Timothy P Walbert
CIK 1349376 · Chairman, President and CEO · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.51M
Companies
14
Total Filings
146
Lifetime Open-Market Net
-$138.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMRN | Director | 17,686 | $55.95 | $989.5K | $0 | 3 | 2026-06-04 |
| MIRM | Director | 9,680 | $99.34 | $961.7K | $0 | 5 | 2026-06-02 |
| ODTX | Director | — | — | — | $0 | 1 | 2026-05-11 |
| IPSC | Director | — | $2.25 | — | $0 | 4 | 2025-06-16 |
| SGMT | Director | — | $6.48 | — | $0 | 3 | 2025-06-10 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Chairman, President and CEO | 0 | $116.30 | $0 | -$138.65M | 79 | 2023-10-06 |
| AUPH | Director | — | $15.82 | — | $0 | 2 | 2022-05-20 |
| XCUR | Director | — | $2.78 | — | $0 | 2 | 2021-06-04 |
| ASRT | Director | 49,143 | $23.48 | $1.15M | $0 | 1 | 2020-05-22 |
| Zyla Life Sciences (EGLT) Delisted | Director | — | — | — | $0 | 5 | 2018-05-15 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 4 | 2018-02-13 |
| XOMA | Director | 129,314 | $41.79 | $5.40M | $0 | 16 | 2017-05-22 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | -$313.5K | 9 | 2014-03-17 |
| IDM PHARMA, INC. (IDMI) Delisted | President and CEO | — | — | — | $0 | 5 | 2008-04-07 |
Recent Filings · Page 9 of 15
146 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-15 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-07 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-27 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +69,625 | -$767.5K | EDGAR |
| 2018-02-13 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Disp (D) | −5,130 | -$92.3K | EDGAR |
| 2018-01-03 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +25,874 | -$354.9K | EDGAR |
| 2017-06-12 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-05 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +5,130 | $0 | EDGAR |
| 2017-05-22 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2017-03-24 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +67,875 | -$831.7K | EDGAR |
| 2017-01-04 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +43,972 | -$610.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.